Quest Diagnostics DGX
NYSE DGX
$247.35 +0.27 (+0.11%)
As of: Sep 17, 2026 · 3:59 PM EDT

Quest Diagnostics (DGX) Divestments (2013 - 2016)

Quest Diagnostics' (DGX) quarterly Divestments came in at $25.0 million in Q4 2016, up 600.0% quarter-over-quarter from -$5.0 million in Q3 2016.

Analysis

Quest Diagnostics (DGX) Divestments (2013 - 2016) Analysis & Trends

Quest Diagnostics has disclosed Divestments across 2 years of filings, most recently posting $25.0 million for Q4 2016.

  • In Q4 2016, Divestments changed N/A year-over-year to $25.0 million; the TTM figure through Sep 2020 stood at $25.0 million (changed N/A YoY), while the FY2021 annual figure was $755.0 million, changed N/A from the prior year.
  • Divestments came in at $25.0 million for Q4 2016 at Quest Diagnostics, up from -$5.0 million in the prior quarter.
  • In the past five years, Divestments ranged from a high of $30.0 million in Q3 2013 to a low of -$5.0 million in Q3 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn -
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn -
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn -
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn -
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn -
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn -
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn -
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn -
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn -
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 25.00 Mn
Sep 30, 2016 -5.00 Mn
Sep 30, 2013 30.00 Mn